標(biāo)題: Titlebook: Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o; Robert Doran Book 2015 The Editor(s) [打印本頁(yè)] 作者: Eschew 時(shí)間: 2025-3-21 19:05
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o影響因子(影響力)
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o影響因子(影響力)學(xué)科排名
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o網(wǎng)絡(luò)公開度
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o被引頻次
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o被引頻次學(xué)科排名
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o年度引用
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o年度引用學(xué)科排名
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o讀者反饋
書目名稱Asymmetric Synthesis of Bioactive Lactones and the Development of a Catalytic Asymmetric Synthesis o讀者反饋學(xué)科排名
作者: Harpoon 時(shí)間: 2025-3-21 23:52 作者: decode 時(shí)間: 2025-3-22 03:03 作者: 音樂(lè)等 時(shí)間: 2025-3-22 04:54 作者: 謊言 時(shí)間: 2025-3-22 10:21 作者: CHOKE 時(shí)間: 2025-3-22 15:11
M. Ataharul Islam,Abdullah Al-Shihaylative protonation of the corresponding α-aryl-β-keto allyl esters. Enantioselectivities of up to 92?% . and 74?% . were achieved for cyclopentanone and cyclohexanone substrates, respectively. The route described gives access to these important structural motifs in moderate to high levels of enanti作者: 釋放 時(shí)間: 2025-3-22 17:52 作者: Triglyceride 時(shí)間: 2025-3-23 00:13
,Introduction to the Development of a Catalytic Asymmetric Synthesis of Tertiary α-Aryl Ketones,Biological systems recognise a pair of enantiomers as different substances and thus each enantiomer will trigger a different response. It is possible that one enantiomer could act positively as a therapeutic agent and the other enantiomer might be very harmful or toxic.作者: entice 時(shí)間: 2025-3-23 03:09
Robert DoranNominated as an outstanding Ph.D. thesis by University College Dublin, Ireland.Outlines the synthesis of a new bioactive lactone-containing natural product analog.Describes the development of a cataly作者: 流逝 時(shí)間: 2025-3-23 06:30 作者: MULTI 時(shí)間: 2025-3-23 10:20
https://doi.org/10.1007/978-3-319-20544-1Antimicrobial Activity; Asymmetric Synthesis; Catalytic Asymmetric Synthesis; Dual Stereocontrol; Natura作者: LIMN 時(shí)間: 2025-3-23 16:57
978-3-319-37034-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: VAN 時(shí)間: 2025-3-23 18:47 作者: Carminative 時(shí)間: 2025-3-23 23:13
2190-5053 natural product analog.Describes the development of a catalyThis thesis addresses two fundamental areas in contemporary organic chemistry: synthesis of natural products and catalytic asymmetric synthesis. Firstly, a new methodology, developed by our research group, which allows the asymmetric synthe作者: intuition 時(shí)間: 2025-3-24 04:18 作者: 講個(gè)故事逗他 時(shí)間: 2025-3-24 09:16
https://doi.org/10.1007/978-3-662-03368-5 due to the poor reactivity of the Grignard reagent derived from 2-(bromomethyl)-1,3-dioxolane. The designed synthetic route enabled us to increase the ring size to generate the δ-lactone analogue employing Sharpless asymmetric epoxidation and ZrCl.-catalysed intramolecular acetalisation as the key steps.作者: sacrum 時(shí)間: 2025-3-24 13:46
Introduction to the Total Synthesis of Lactone-Containing Natural Products Using ZrCl4, greatest source of potential new pharmaceuticals. The discovery and application of new and interesting methodologies of use in total synthesis is vital to the goals of designing shorter, more elegant and ultimately more reliable syntheses of natural products and analogues.作者: 來(lái)就得意 時(shí)間: 2025-3-24 18:40 作者: Analogy 時(shí)間: 2025-3-24 19:33
https://doi.org/10.1007/978-3-662-03368-5 β-methyl group would have on the bioactivity of these compounds. The biological testing of these compounds revealed that none of these analogues showed any antifungal activity however, one of the analogues of malyngolide showed promising activity against MRSA with an MIC of 12.5?μg/mL.作者: 慢慢啃 時(shí)間: 2025-3-25 02:58
M. Ataharul Islam,Abdullah Al-Shihalows for simple modification of the aryl group and, significantly, substrates containing sterically hindered aryl groups gave the highest levels of enantioselectivity and these aryl groups were readily installed by a Pb-mediated arylation of a β-keto allyl ester.作者: 周年紀(jì)念日 時(shí)間: 2025-3-25 04:05 作者: 滔滔不絕的人 時(shí)間: 2025-3-25 09:58 作者: 不能平靜 時(shí)間: 2025-3-25 15:41 作者: Fantasy 時(shí)間: 2025-3-25 16:14
A Stereoselective Switch: Enantiodivergent Approach to the Synthesis of Isoflavanones,ereocontrol in an asymmetric protonation reaction whereby the same chiral ligand is used with a different achiral proton donor. The first enantioselective synthesis of the naturally occurring isoflavanones sativanone and 3-.-methylviolanone has also been accomplished using this methodology.作者: aristocracy 時(shí)間: 2025-3-25 21:02 作者: 繼承人 時(shí)間: 2025-3-26 03:11
Introduction to the Total Synthesis of Lactone-Containing Natural Products Using ZrCl4,s continues to be one of the most fascinating and well-studied areas of organic chemistry. Natural products and designed analogues continues to be the greatest source of potential new pharmaceuticals. The discovery and application of new and interesting methodologies of use in total synthesis is vit作者: 離開 時(shí)間: 2025-3-26 06:18 作者: 有組織 時(shí)間: 2025-3-26 09:48 作者: 無(wú)能的人 時(shí)間: 2025-3-26 15:47 作者: FLOUR 時(shí)間: 2025-3-26 16:56 作者: TRUST 時(shí)間: 2025-3-26 21:57 作者: inconceivable 時(shí)間: 2025-3-27 04:32 作者: 遺傳學(xué) 時(shí)間: 2025-3-27 08:17
9樓作者: grenade 時(shí)間: 2025-3-27 11:51
9樓作者: 創(chuàng)作 時(shí)間: 2025-3-27 15:32
9樓作者: 干涉 時(shí)間: 2025-3-27 21:14
9樓作者: 的事物 時(shí)間: 2025-3-27 23:58
10樓作者: 財(cái)主 時(shí)間: 2025-3-28 03:42
10樓作者: Neuralgia 時(shí)間: 2025-3-28 09:56
10樓作者: Cognizance 時(shí)間: 2025-3-28 12:58
10樓